| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |